30 April 2015 - Deborah Wilkes
Archived
Pfizer Consumer Healthcare's US sales rose by 17% in the first quarter of 2015 following the launch of Nexium 24HR a year ago. Chief executive officer Ian Read said the business "is strategically important" to Pfizer.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.